What was the outcome of the director elections at the annual meeting?

All nine nominated directors were overwhelmingly elected for a one-year term, receiving substantial support from shareholders. This indicates strong shareholder confidence in the current board's leadership and governance.

How did shareholders vote on executive compensation?

Shareholders approved the company's executive compensation through a non-binding advisory vote, with a significant majority voting in favor. They also overwhelmingly supported holding these advisory 'Say-on-Pay' votes on an annual basis.

Were there any shareholder proposals that passed?

No, all six shareholder proposals presented at the meeting failed to receive majority shareholder approval. These included proposals related to racial equity audits, political contributions reporting, and termination pay ratification.

Is there any upcoming event where UNH leadership will discuss company performance or strategy?

Yes, senior leaders from UnitedHealth Group will participate in an interview format at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023. They will discuss the company's strategy, market positions, recent results, and outlook. A live audio webcast will be available on the company's Investor Relations website.

UNH 8-K: Shareholder Matters & Regulation FD

Summary

This 8-K filing from UnitedHealth Group Inc. (UNH) details the outcomes of their 2023 Annual Meeting of Shareholders held on June 5, 2023. Key for investors is the overwhelming support shown for the re-election of all nine directors, indicating strong shareholder confidence in the current leadership. Additionally, shareholders provided a non-binding advisory vote approving the company's executive compensation and overwhelmingly favored holding these advisory votes on an annual basis. The appointment of Deloitte & Touche LLP as the independent auditor was also ratified with significant support. Notably, several shareholder proposals, including those related to a third-party racial equity audit, a political contributions congruency report, and shareholder ratification of termination pay, did not receive majority support. The filing also announces that senior leaders will be participating in an interview at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023, to discuss strategy, market positions, recent results, and outlook, which will be webcast live.

Key Highlights

1All nine nominated directors were overwhelmingly re-elected for a one-year term, signifying strong shareholder confidence in the board.
2Shareholders provided a non-binding advisory vote approving the company's executive compensation, with a significant majority in favor.
3A substantial majority of shareholders voted in favor of holding advisory votes on executive compensation (Say-on-Pay) on an annual basis.
4The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023, was ratified by shareholders.
5Three shareholder proposals—seeking a racial equity audit, a political contributions congruency report, and ratification of termination pay—failed to gain majority shareholder approval.
6UnitedHealth Group leadership will participate in a fireside chat at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023, to discuss strategy and outlook, with a live webcast available.

UNITEDHEALTH GROUP INC 8-K Report, Shareholder Vote Results (Jun 9, 2023)

Summary

Key Highlights

Frequently Asked Questions